{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:23Z","timestamp":1786997603125,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.transci.2024.103965","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T01:02:11Z","timestamp":1719882131000},"page":"103965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insight into hazards and control of transfusion-transmitted infections in Egypt: A narrative review"],"prefix":"10.1016","volume":"63","author":[{"given":"Hazem A.","family":"Sayed Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Mohamed","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.103965_bib1","series-title":"Global Status Report on Blood Safety and Availability 2021","author":"World Health Organization (WHO","year":"2022"},{"key":"10.1016\/j.transci.2024.103965_bib2","series-title":"User Guide for Navigating Resources on Stepwise Implementation of haemovigilance Systems","author":"World Health Organization (WHO","year":"2022"},{"issue":"2","key":"10.1016\/j.transci.2024.103965_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7861\/clinmed.2022-0401","article-title":"Challenges for maintaining the microbiological safety of the UK blood supply","volume":"23","author":"Neuberger","year":"2023","journal-title":"Clin Med (Lond)"},{"issue":"17","key":"10.1016\/j.transci.2024.103965_bib4","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2018-11-833996","article-title":"Prevention of transfusion-transmitted infections","volume":"133","author":"Busch","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12879-020-05344-5","article-title":"Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013-2017","volume":"20","author":"Aabdien","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.transci.2024.103965_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-030-36966-8_8","article-title":"Blood transfusion-associated infections in the twenty-first century: new challenges","author":"Fong","year":"2020","journal-title":"Curr Trends Concerns Infect Dis"},{"issue":"7","key":"10.1016\/j.transci.2024.103965_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/pathogens12070911","article-title":"Emerging pathogen threats in transfusion medicine: improving safety and confidence with pathogen reduction technologies","volume":"12","author":"Cardoso","year":"2023","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.transci.2024.103965_bib8","first-page":"409","article-title":"Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018","volume":"17","author":"Velati","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2024.103965_bib9","unstructured":"World Health Organization (WHO). Blood safety and availability [Internet]: WHO; 2023. [cited 2024 Mar 1]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability."},{"issue":"12","key":"10.1016\/j.transci.2024.103965_bib10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and treatment program to eliminate hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transci.2024.103965_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tmrv.2019.01.001","article-title":"Transfusion-transmitted infections reported to the national healthcare safety network hemovigilance module","volume":"33","author":"Haass","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"3","key":"10.1016\/j.transci.2024.103965_bib12","first-page":"288","article-title":"Ways To enhance blood transfusion safety: a systematic review","volume":"30","author":"Nayeri","year":"2022","journal-title":"Florence Nightingale J Nurs"},{"key":"10.1016\/j.transci.2024.103965_bib13","article-title":"Evaluation of transfusion transmissible infections prevalence and trend among blood donors attended at Bule Hora blood bank, West Guji, South Ethiopia","volume":"9","author":"Aliyo","year":"2022","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"12","key":"10.1016\/j.transci.2024.103965_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/14728222.2023.2199923","article-title":"Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies","volume":"27","author":"Baiardi","year":"2023","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"10.1016\/j.transci.2024.103965_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/trf.16262","article-title":"Bacterial contamination of blood products in Africa","volume":"61","author":"Ahmad","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103965_bib16","unstructured":"Centers for Disease Control and Prevention (CDC). Blood Safety: Diseases and Organisms [Internet]. CDC; 2022 [cited 2024 Mar 2]. Available from: https:\/\/www.cdc.gov\/bloodsafety\/bbp\/diseases-organisms.html."},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13054-018-2212-9","article-title":"Bacterial contamination of platelets for transfusion: strategies for prevention","volume":"22","author":"Levy","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2024.103965_bib18","unstructured":"World Health Organization (WHO). Data on Syphilis [Internet]: WHO; 2023. [cited 2024 Mar 8]. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/data-on-syphilis."},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC laboratory recommendations for Syphilis testing, United States, 2024","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.transci.2024.103965_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.disamonth.2018.01.005","article-title":"Tick borne illness \u2013 Anaplasmosis","volume":"64","author":"McFee","year":"2018","journal-title":"Dis Mon"},{"key":"10.1016\/j.transci.2024.103965_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117280","article-title":"Brucellosis","volume":"420","author":"Shakir","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.transci.2024.103965_bib22","unstructured":"Centers for Disease Control and Prevention (CDC). Ehrlichiosis [Internet]. CDC; 2022 [cited 2024 Mar 2]. Available from: https:\/\/www.cdc.gov\/ehrlichiosis\/index.html."},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/v15010086","article-title":"Viruses special issue transfusion-transmitted viral infections","volume":"15","author":"Candotti","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12889-023-15490-5","article-title":"Trends of HIV indicators in Egypt from 1990 to 2021: time-series analysis and forecast toward UNAIDS 90-90-90 targets","volume":"23","author":"Ghazy","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.transci.2024.103965_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7027169","article-title":"A systematic review of the current hepatitis B viral infection and hepatocellular carcinoma situation in Mediterranean countries","volume":"2020","author":"Madihi","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.transci.2024.103965_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43066-022-00207-x","article-title":"The prevalence and determinants of hepatitis B among Egyptian adults: a further analysis of a country-representative survey","volume":"12","author":"Raslan","year":"2022","journal-title":"Egypt Liver J"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12879-023-08110-5","article-title":"Seroprevalence of hepatitis B virus surface antigen (HBsAg) in Egypt (2000-2022): a systematic review with meta-analysis","volume":"23","author":"Azzam","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.transci.2024.103965_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s42506-023-00138-4","article-title":"Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis","volume":"98","author":"Azzam","year":"2023","journal-title":"J Egypt Public Health Assoc"},{"issue":"6","key":"10.1016\/j.transci.2024.103965_bib29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.26719\/2018.24.6.595","article-title":"Blood transfusion and hepatitis : what does it take to prevent new infections?","volume":"24","author":"Abdella","year":"2018","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.transci.2024.103965_bib30","unstructured":"World Health Organization (WHO). hepatitis C [Internet]: WHO; 2023. [cited 2024 Mar 3]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ hepatitis -c."},{"key":"10.1016\/j.transci.2024.103965_bib31","series-title":"Egypt becomes the first country to achieve WHO validation","article-title":"on the path to elimination of hepatitis C [Internet","author":"World Health Organization (WHO","year":"2024"},{"key":"10.1016\/j.transci.2024.103965_bib32","unstructured":"World Health Organization (WHO). WHO commends Egypt for its progress on the path to eliminate hepatitis C [Internet]: WHO; 2023. [cited 2024 Mar 3]. Available from: https:\/\/www.who.int\/news\/item\/09\u201310-2023-who-commends-egypt-for-its-progress-on-the-path-to-eliminate- hepatitis -c."},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12879-019-4190-1","article-title":"Why all blood donations should be tested for hepatitis E virus (HEV)","volume":"19","author":"Denner","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.transci.2024.103965_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/1348-0421.12916","article-title":"Current situation of viral hepatitis in Egypt","volume":"65","author":"Elbahrawy","year":"2021","journal-title":"Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.transci.2024.103965_bib35","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/v13091753","article-title":"Work-related human T-lymphotropic Virus 1 and 2 (HTLV-1\/2) infection: a systematic review","volume":"13","author":"Stufano","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.transci.2024.103965_bib36","first-page":"446","article-title":"Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland","volume":"18","author":"Voruz","year":"2020","journal-title":"Blood Transfus"},{"issue":"8","key":"10.1016\/j.transci.2024.103965_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211034656","article-title":"Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis","volume":"49","author":"Adane","year":"2021","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.transci.2024.103965_bib38","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3201\/eid2506.181755","article-title":"West Nile and Usutu virus infections and challenges to blood safety in the European union","volume":"25","author":"Domanovi\u0107","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.transci.2024.103965_bib39","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/S2666-5247(23)00170-2","article-title":"Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation","volume":"4","author":"Gould","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.transci.2024.103965_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejogrb.2021.07.012","article-title":"Zika virus infection in pregnant women and their children: a review","volume":"265","author":"Marb\u00e1n-Castro","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.transci.2024.103965_bib41","unstructured":"World Health Organization (WHO). Zika virus [Internet]: WHO; 2022. [cited 2024 Mar 3]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/zika-virus."},{"issue":"2","key":"10.1016\/j.transci.2024.103965_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(18)30018-5","article-title":"Re-emergence of Aedes aegypti in Egypt","volume":"18","author":"Abozeid","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.transci.2024.103965_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab146","article-title":"Global burden for dengue and the evolving pattern in the past 30 years","volume":"28","author":"Yang","year":"2021","journal-title":"J Travel Med"},{"issue":"9","key":"10.1016\/j.transci.2024.103965_bib44","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.transci.2024.103965_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2020.e00141","article-title":"Prevention strategies of transfusion-transmitted parasitic infections (TTPIs): strengths and challenges of current approaches, and evaluation of the strategies implemented in Iran","volume":"9","author":"Mardani","year":"2020","journal-title":"Parasite Epidemiol Control"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12936-018-2181-0","article-title":"A systematic review of transfusion-transmitted malaria in non-endemic areas","volume":"17","author":"Verra","year":"2018","journal-title":"Malar J"},{"issue":"7","key":"10.1016\/j.transci.2024.103965_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz283","article-title":"Transfusion-transmitted malaria: a systematic review and meta-analysis","volume":"6","author":"Ahmadpour","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib48","article-title":"Molecular screening for Malaria among blood donors in a WHO claimed region of Egypt, Fayoum governorate","volume":"9","author":"Edris","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/tme.12741","article-title":"Screening of at-risk blood donors for Chagas disease in non-endemic countries: Lessons from a 2-year experience in Tuscany, Italy","volume":"31","author":"Mangano","year":"2021","journal-title":"Transfus Med"},{"issue":"11","key":"10.1016\/j.transci.2024.103965_bib50","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/pathogens10111447","article-title":"The global emergence of human babesiosis","volume":"10","author":"Kumar","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.transci.2024.103965_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2022.100443","article-title":"Tick-borne diseases in Egypt: a one health perspective","volume":"15","author":"Abdelbaset","year":"2022","journal-title":"One Health"},{"issue":"5","key":"10.1016\/j.transci.2024.103965_bib52","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4269\/ajtmh.21-1120","article-title":"Failure to detect Leishmania in the blood of patients with old-world cutaneous Leishmaniasis: implications for blood donation","volume":"107","author":"Solomon","year":"2022","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.transci.2024.103965_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011142","article-title":"Detection of asymptomatic Leishmania infection in blood donors at two blood banks in Ethiopia","volume":"17","author":"Mohammed","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.transci.2024.103965_bib54","first-page":"741","article-title":"International Society of Blood Transfusion Ttid Working Party Parasite Subgroup","volume":"116","author":"Drews","year":"2021"},{"key":"10.1016\/j.transci.2024.103965_bib55","unstructured":"Centers for Disease Control and Prevention (CDC). Prion Diseases [Internet]. CDC; 2021 [cited 2024 Mar 3]. Available from: https:\/\/www.cdc.gov\/prions\/index.html."},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1182\/hematology.2022000402","article-title":"Platelet components and bacterial contamination: hospital perspective 2022","volume":"2022","author":"Szczepiorkowski","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.transci.2024.103965_bib57","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/trf.16250","article-title":"HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men","volume":"61","author":"Steele","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103965_bib58","series-title":"Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia region to support universal health coverage","author":"World Health Organization (WHO)","year":"2023"},{"issue":"11","key":"10.1016\/j.transci.2024.103965_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277650","article-title":"Reducing the risk of transfusion-transmitted infectious disease markers in blood and blood component donations: movement from remunerated to voluntary, non-remunerated donations in Lithuania from 2013 to 2020","volume":"17","author":"Kalibatas","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.transci.2024.103965_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246704","article-title":"Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: the incidence\/window-period model study","volume":"16","author":"Grubyte","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.transci.2024.103965_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00352-18","article-title":"Transfusion-transmitted infections: an update on product screening, diagnostic techniques, and the path ahead","volume":"56","author":"Dean","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.transci.2024.103965_bib62","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/trf.15344","article-title":"Proceedings of the food and drug administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)","volume":"59","author":"Atreya","year":"2019","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.transci.2024.103965_bib63","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/trf.15456","article-title":"Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation","volume":"59","author":"Shigemura","year":"2019","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2024.103965_bib64","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2023-178182","article-title":"Cytomegalovirus-seronegative plus leukoreduced blood products are still superior to only leukoreduced products in preventing transfusion-transmitted cytomegalovirus infection","volume":"142","author":"Yakushijin","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.transci.2024.103965_bib65","series-title":"Establishing External Quality Assessment Programmes for Screening of Donated Blood for Transfusion-transmissible Infections: Implementation Guide","author":"World Health Organization (WHO","year":"2016"},{"key":"10.1016\/j.transci.2024.103965_bib66","series-title":"Availability, safety and quality of blood products","author":"World Health Organization (WHO","year":"2022"},{"issue":"4","key":"10.1016\/j.transci.2024.103965_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/tme.12582","article-title":"International haemovigilance : what have we learned and what do we need to do next?","volume":"29","author":"Wood","year":"2019","journal-title":"Transfus Med"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2024.103965_bib68","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ijlh.12834","article-title":"Challenges to laboratory hematology practice: Egypt perspective","volume":"40","author":"Rizk","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.transci.2024.103965_bib69","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00277-024-05657-4","article-title":"Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using 'Adapted ADAPTE","volume":"103","author":"Mokhtar","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.transci.2024.103965_bib70","unstructured":"World Health Organization (WHO) Regional Office for the Eastern Mediterranean. Summary Report on the Regional Consultation on the Global Health Sector Strategies (GHSS) on HIV, hepatitis and STIs, 2022\u20132030. Cairo: WHO Regional Office for the Eastern Mediterranean; 2021. Licence: CC BY-NC-SA 3.0 IGO. [cited 2024 Mar 6]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv- hepatitis -and-stis-library\/emro_ghss_regional_consultation_report_2021.pdf?sfvrsn=75400c38_5."}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:11:28Z","timestamp":1732327888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1473050224001332"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103965","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into hazards and control of transfusion-transmitted infections in Egypt: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103965"}}